Project Aim
Usher Syndrome is a rare genetic disorder that results in a combination of deafness and blindness due to Retinitis Pigmentosa (RP). Retinal gene therapy, a potential future treatment to prevent blindness in people with Usher Syndrome, has come along way in the last decades with the exponential development and improvement in gene delivery technologies.
However, the genes responsible for certain types of Usher Syndromes, like type 1F and 1B, are too large for traditional gene therapy approaches that use an adeno-associated virus (AAV) vector.
This project will explore the split gene treatment approach, called dual AAV approach, to test its therapeutic potential for Usher type 1F caused by mutations in the PCDH15 gene. This will be performed by deriving induced pluripotent stem cells (iPSCs) from skin fibroblasts from an Usher 1F patient and generating patient-specific retinal organoids (“retina in a dish”) for evaluation of the AAV treatment approach.
Project Results and Impact
This Retina Australia grant has allowed us to develop an effective in vitro model for Usher 1F and demonstrate proof-of-principle expression restoration of PCDH15 using dual AAV vectors.
Low-level dosage of hybrid AAV2/9 vectors was the most effective strategy tested to induce PCDH15 expression.
Overall, our results are a starting point for follow-up studies, which can aim to investigate the viability of an optimised dual AAV approach for the therapeutic delivery of PCDH15 to Usher 1F patients.
Chief investigator:
Dr Livia S Carvalho
Lions Eye Institute, Perth
Co-investigator/s:
Dr Carla B Mellough, Lions Eye Institute, Perth
Dr Fred K Chen, Centre for Ophthalmology and Visual Sciences, The University of Western Australia
Grant awarded:
$40,000 (2019)
Research Impact Reports
Improving real-world mobility and assessing long-term safety outcomes with a retinal prosthesis (“Bionic Eye”)
Project Aim This project aimed to measure visual outcomes of...
RNA base editing strategies as potential therapeutic of inherited retinal dystrophies
Project Aim This study aimed to use a new genetic...
Neuroprotective effect of SAHA in Retinitis Pigmentosa. Do time and frequency matter?
Project Aim Retinitis Pigmentosa (RP) is a genetic, blinding retinal...
Read more about Improving Sensory Substitution Low Vision Devices Through Novel Software Adaptations
Improving Sensory Substitution Low Vision Devices Through Novel Software Adaptations
Project Aim To investigate the efficacy of sensory substitution devices...